FR2375867A1 - Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu - Google Patents

Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu

Info

Publication number
FR2375867A1
FR2375867A1 FR7739353A FR7739353A FR2375867A1 FR 2375867 A1 FR2375867 A1 FR 2375867A1 FR 7739353 A FR7739353 A FR 7739353A FR 7739353 A FR7739353 A FR 7739353A FR 2375867 A1 FR2375867 A1 FR 2375867A1
Authority
FR
France
Prior art keywords
dehydro
resolution
intended
oligopeptides
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7739353A
Other languages
English (en)
French (fr)
Other versions
FR2375867B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762659154 external-priority patent/DE2659154A1/de
Priority claimed from DE19772745673 external-priority patent/DE2745673A1/de
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of FR2375867A1 publication Critical patent/FR2375867A1/fr
Application granted granted Critical
Publication of FR2375867B1 publication Critical patent/FR2375867B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7739353A 1976-12-28 1977-12-27 Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu Granted FR2375867A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762659154 DE2659154A1 (de) 1976-12-28 1976-12-28 Tumor- und gewebsaufloesende arzneimittel
DE19772745673 DE2745673A1 (de) 1977-10-11 1977-10-11 Tumor- und gewebsaufloesende arzneimittel

Publications (2)

Publication Number Publication Date
FR2375867A1 true FR2375867A1 (fr) 1978-07-28
FR2375867B1 FR2375867B1 (enExample) 1980-06-13

Family

ID=25771321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7739353A Granted FR2375867A1 (fr) 1976-12-28 1977-12-27 Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu

Country Status (5)

Country Link
US (1) US4310517A (enExample)
JP (1) JPS5386043A (enExample)
AU (1) AU514183B2 (enExample)
FR (1) FR2375867A1 (enExample)
GB (1) GB1570140A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010830A3 (en) * 1978-07-03 1980-10-15 Research Corporation Dehydropeptides
EP0017705A1 (de) * 1979-02-07 1980-10-29 Troponwerke GmbH & Co. KG Phenylalanyltryptophan-Derivate, sie enthaltende Arzneimittel, ihre Herstellung und Verwendung
FR2597476A1 (fr) * 1986-04-22 1987-10-23 Ajinomoto Kk Composes benzylideniques, compositions les contenant et agents absorbant le rayonnement ultraviolet constitues par ces composes.
US5000945A (en) * 1986-04-22 1991-03-19 Ajinomoto Co., Inc. Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3127930A1 (de) * 1981-07-15 1983-01-27 A. Nattermann & Cie GmbH, 5000 Köln Neue optisch aktive dipeptide, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate
FR2533209B1 (fr) * 1982-09-22 1985-11-08 Centre Nat Rech Scient Lipopeptides, leur obtention et leur application comme emulsifiants
US4504414A (en) * 1983-03-28 1985-03-12 Board Of Regents, The University Of Texas System Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
US4642332A (en) * 1985-04-26 1987-02-10 The Board Of Regents, The University Of Texas System Effective hormonal peptides: D-3-Pal6 -LHRH
US4656247A (en) * 1985-04-26 1987-04-07 Board Of Regents, The University Of Texas System Effective hormonal peptides: D-3-QA1 6-LHRH
US4996348A (en) * 1987-07-29 1991-02-26 Ciba-Geigy Corporation N-alkenoyl enamides, their preparation and the use thereof
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
EP0701446A4 (en) * 1993-05-24 1997-04-23 Smithkline Beecham Corp HEMOREGULATORS PEPTIDES
AU2926097A (en) * 1996-04-25 1997-11-12 Arqule, Inc. Immunosuppressive compounds from an arylidene diamide array
AU5923998A (en) * 1997-01-31 1998-08-25 Avid Therapeutics Inc. 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
CN1301253C (zh) * 2003-07-31 2007-02-21 中国人民解放军军事医学科学院毒物药物研究所 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途
US8148571B2 (en) * 2006-09-29 2012-04-03 Kuraray Medical Inc. Compound, composition comprising the same, and process for production of polymerizable amide
US11155528B2 (en) 2019-10-25 2021-10-26 King Abdulaziz University Bis-propenamide compounds and methods of treating cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV6013/64 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010830A3 (en) * 1978-07-03 1980-10-15 Research Corporation Dehydropeptides
EP0017705A1 (de) * 1979-02-07 1980-10-29 Troponwerke GmbH & Co. KG Phenylalanyltryptophan-Derivate, sie enthaltende Arzneimittel, ihre Herstellung und Verwendung
FR2597476A1 (fr) * 1986-04-22 1987-10-23 Ajinomoto Kk Composes benzylideniques, compositions les contenant et agents absorbant le rayonnement ultraviolet constitues par ces composes.
US4985237A (en) * 1986-04-22 1991-01-15 Ajinomoto Co., Inc. Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same
US5000945A (en) * 1986-04-22 1991-03-19 Ajinomoto Co., Inc. Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same

Also Published As

Publication number Publication date
GB1570140A (en) 1980-06-25
AU3191277A (en) 1979-06-28
US4310517A (en) 1982-01-12
JPS5386043A (en) 1978-07-29
FR2375867B1 (enExample) 1980-06-13
AU514183B2 (en) 1981-01-29

Similar Documents

Publication Publication Date Title
FR2375867A1 (fr) Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
MX171191B (es) Composiciones farmaceuticas de glipizida
IL81349A (en) Vinylphenol derivatives,their preparation and pharmaceutical compositions containing them
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
GEP20033094B (en) Steroid Sulphatase Inhibitors
ATE113203T1 (de) Darreichnungsform zur verabreichnung eines antiparkinsonsmittel.
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
KR970025615A (ko) 암 전이 억제제
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
IT1181682B (it) Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
FR2500303B1 (enExample)
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
FR2376128A1 (fr) Nouveaux dehydro-oligopeptides, leur procede de preparation et medicament les contenant
ES2040765T3 (es) Procedimiento para preparar un agente para el tratamiento de enfermedades angiogenas o tumores.
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
TR199901958T2 (xx) �nfertiliteye kar�� ve fertiliteyi art�rmak i�in bir ila�.
BE862329A (fr) Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu

Legal Events

Date Code Title Description
ST Notification of lapse